Statin-Myopathie
Über den Vortrag
Der Vortrag „Statin-Myopathie“ von Roy Strowd, MD ist Bestandteil des Kurses „Erworbene neuromuskuläre Erkrankungen“.
Quiz zum Vortrag
Which statin drug is associated with the highest risk of myopathy?
- Simvastatin
- Pravastatin
- Fluvastatin
- Atorvastatin
- Rosuvastatin
Which antibody is associated with statin-induced necrotizing autoimmune myositis?
- Anti-HMG-CoA reductase antibody
- Anti-Jo-1 antibody
- Anti-double-stranded DNA antibody
- Anti-Mi-2 antibody
- Anti-nuclear antibody
What is the first step in the management of statin-induced myopathy in a patient whose creatine kinase value is more than four times the upper limit of normal?
- Ruling out rhabdomyolysis
- Ruling out necrotizing autoimmune myositis
- Lowering the drug dose
- Changing to another lipid-lowering agent
- Stopping the drug for 6–8 weeks
Which of the following clinical features is associated with mild statin myopathy?
- Myalgia
- Myxedema
- Persistence of muscle weakness after statin withdrawal
- Renal impairment
- Metabolic acidosis and electrolyte abnormalities
Diese Kurse könnten Sie interessieren
Dozent des Vortrages Statin-Myopathie
Roy Strowd, MD
Dr. Roy Strowd is the Assistant Dean of Undergraduate Medical Education at the Wake Forest Baptist Medical Center, in North Carolina, USA.
He obtained his MD from Wake Forest School of Medicine in 2009, and his MEd from Johns Hopkins University in 2021. Currently, he co-directs the Neurofibromatosis and Tuberous Sclerosis Clinics at Wake Forest Baptist Medical Center, and is a researcher for the Adult Brain Tumor Consortium (ABTC) and Alliance for Clinical Trials in Neuro-Oncology.
Due to his achievements, he earned the M. Brownell Anderson Award from the Association of American Medical Colleges.
Within Lecturio, Dr. Strowd teaches courses on Clinical Neurology.
Kundenrezensionen
5,0 von 5 Sternen
| 5 Sterne |
|
5 |
| 4 Sterne |
|
0 |
| 3 Sterne |
|
0 |
| 2 Sterne |
|
0 |
| 1 Stern |
|
0 |
